Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Gilead Sciences has agreed to acquire Immunomedics, a Morris Plains, New Jersey-based clinical-stage biopharmaceutical company focused on antibody-drug conjugates (ADCs), for $21 billion. Immunomedics’ lead product is Trodelvy (sacituzumab...

The US Department of Health and Human Services (HHS) and the US Department of Defense (DoD) released two documents outlining the US government’s strategy to deliver COVID-19 vaccine doses once vaccines are proven effective and safe and are...

A roundup of news from Germany (Bayer, Recursion), India (Mylan), Spain (Grifols, Alkahest), and the US (Merck KGaA, Pfizer, NKMax America). Germany Bayer, Recursion in AI Drug-Discovery Pact; Bayer Takes $50-M StakeBayer and Recursion...

AbbVie and I-Mab, a clinical-stage biopharmaceutical company headquartered in Shanghai, have signed a broad, global collaboration agreement, in a deal worth up to $1.94 billion, for the development and commercialization of lemzoparlimab, an...

A roundup of news from the UK (Takeda, Engitix Therapeutics, Intract Pharma, Celltrion), and the US (Gilead Sciences, Jounce Therapeutics, Mylan, Biocon, and Ionis). UK Takeda, Engitix in $500-M Pact To Develop Anti-Fibrotic Therapies Engitix...

The European Commission has signed an agreement with AstraZeneca for the purchase of up to 400 million doses of AstraZeneca’s COVID-19 vaccine. Also, AstraZeneca signed supply pacts with AMRI and Oxford Biomedica and provided an update on the...

The US Food and Drug Administration (FDA) has issued guidance, Control of Nitrosamine Impurities in Human Drugs, for immediate implementation. The guidance recommends steps, including a comprehensive risk-assessment strategy and other actions...